Philippine Alliance of Patient Organizations

A COALITION OF PATIENT ORGANIZATIONS ADVOCATING FOR UNIVERSAL ACCESS TO HEALTHCARE AND ALLIED SERVICES

HISTORY

The consumer-based Health Care Advocacy Project sparked the creation of PAPO. 

Implemented from 2002 to 2007 by The Asia Foundation (TAF) with support from the Pfizer Foundation, the project enabled many patient groups and health NGOs to:

STRENGTHEN – organizational and fundraising capabilities

INFLUENCE – health policymaking through engagement with local- and national-level government representatives

BUILD – their institutional capacity in volunteer management

BOARD MEMBERS

Karen Alparce-Villanueva

President

Fatima Garcia- Lorenzo

Founder, Immediate Past President and Adviser

Kara Alikpala

Founding Member, Past Board Member, and Adviser

Chris Munoz

Vice President

Ara Lanorio

Secretary

Cynthia Magdarog

Treasurer

Nelia Medina

Trustee

Mel Lamsin

Trustee

Eins Rojas

Trustee

OBJECTIVES

Actively participate in policymaking decisions concerning patient rights

Safeguard the strict implementation of laws and policies affecting patient needs

Create a registry and database of patients and patient organizations

Provide a venue for information dissemination and education on patient rights

Partner with local and international stakeholders in promoting patient rights

Serve as a clearinghouse of information and alerts on patient issues and concerns

Serve as a forum for discussion of issues, concerns, laws, and policies
concerning patients and patient organizations

Help patients access information on and utilize PhilHealth services

Help patients and PWDs avail of relevant discounts and health services

Provide training on resource mobilization and fundraising, advocacy, and volunteer management

Provide psychosocial services training to patient organizations,
particularly on coping and living with illnesses and disability

Liaise with the Department of Health, Local Government Units, and relevant government agencies, Senate and House representatives, pharmaceutical companies, and the International Alliance of Patient Organizations (IAPO)